SearchPeter Ronco is President of IQVIA Biotech, a specialized business unit within IQVIA dedicated to providing clinical development solutions for biotech and emerging biopharma companies. He is responsible for the strategic direction, operational excellence, and delivery of high-quality clinical programs across the IQVIA Biotech portfolio.
Peter brings more than 30 years of experience leading global development organizations across the pharmaceutical and biotech sectors. He has a deep track record in designing efficient drug development programs and advancing innovative approaches to trial design and execution, supporting sponsors across all phases and therapeutic areas.
Prior to joining IQVIA Biotech, Peter served as President and CEO of Emmes Corp, a specialty contract research organization focused on biotech companies and multiple institutes within the U.S. National Institutes of Health. Earlier, he was Head of Global Development at Johnson & Johnson Innovative Medicine, where he was accountable for a portfolio of more than 450 studies spanning all therapeutic areas and phases. Peter has also held senior leadership roles in global clinical operations, regulatory operations, and medical affairs at Johnson & Johnson and Bristol Myers Squibb.
Peter holds a degree from the University of Nottingham in the United Kingdom.